SCHEMBL6876994

SCHEMBL6876994

CCCCCC(=O)N[C@H]1CC[C@@H](Nc2cc(N(C)C)c3ccccc3n2)CC1

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
GAA P10253 2/20 0.50
HPGD P15428 2/20 0.50
TSHR P16473 2/20 0.50
HSD17B10 Q99714 2/20 0.50
GLA P06280 1/20 0.50
MAPK1 P28482 1/20 0.50
CNR2 P34972 14/20 0.47
CNR1 P21554 11/20 0.47
MCHR1 Q99705 2/20 0.46
ADRA2A P08913 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6877000 1.00 KDM4E (0.50) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL6878289 0.90 KDM4E (0.48) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL6878294 0.90 KDM4E (0.48) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL6874823 0.88 CNR2 (0.48) HPGDCNR2CNR1MCHR1ADRA2A
SCHEMBL6874816 0.88 CNR2 (0.48) HPGDCNR2CNR1MCHR1ADRA2A
SCHEMBL6875053 0.87 MCHR1 (0.49) KDM4EMCHR1ADRA2A
SCHEMBL6875056 0.87 MCHR1 (0.49) KDM4EMCHR1ADRA2A
SCHEMBL6877947 0.87 EPHX1 (0.46) MCHR1ADRA2A
SCHEMBL6877940 0.87 EPHX1 (0.46) MCHR1ADRA2A
SCHEMBL6872993 0.86 MCHR1 (0.51) KDM4EMCHR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100451004-C Pyrimidine derivatives ARENA PHARM INC (JP) 2009-01-14 CN disclosed
CN-1798736-A Novel quinoline, tetrahydroquinazoline and pyrimidine derivatives and methods of treatment related to their use ARENA PHARM INC (JP) 2006-07-05 CN disclosed
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed